Ascendis Pharma A/S (ASND)
NMS – Real vaqt narxi. Valyuta: USD
260.75
-0.83 (-0.32%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
261.00
+0.25 (0.10%)
Bozordan keyin: Jun 26, 2026, 4:48 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
260.75
-0.83 (-0.32%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
261.00
+0.25 (0.10%)
Bozordan keyin: Jun 26, 2026, 4:48 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $1.0B naqd pul zahiralaridan ($660.0M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $1.3B jami joriy majburiyatlarni $1.3B zo'rg'a qoplaydi, bu cheklangan likvidlikni ko'rsatadi
Qarz/kapital nisbati (1.8) tarmoq o'rtachasidan ancha yuqori bo'lib, haddan tashqari leverajni aks ettiradi
Foiz qoplash koeffitsiyenti (0.4x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$18.1M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 1.00 | 6.05 | 6.0 | |
| Tezkor likvidlik nisbati | 0.72 | 5.63 | 4.0 | |
| Qarz/Kapital nisbati | 1.84 | 0.30 | 3.0 | |
| Qarz/Aktivlar nisbati | 0.45 | 1.04 | 5.0 | |
| Foiz to‘lov qoplami | 0.37 | -16.91 | 2.0 | |
| O‘rtacha ball | 4.0 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 54M | 288M | 393M | 813M | 1.01B |
| Yalpi foyda | 26M | 225M | 333M | 691M | 878M |
| Operatsion daromad | -590M | -492M | -302M | -154M | -7M |
| Sof foyda | -613M | -520M | -409M | -257M | 582M |
| EBITDA | -572M | -472M | -282M | -134M | 14M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 99.77 | 277.99 | 10 |
| Keyingi chorak | 58.95 | 210.56 | 10 |
| Joriy yil | 78.93 | 444.78 | 10 |
| Keyingi yil | 45.39 | -29.45 | 5.5 |
| O‘rtacha ball | 8.9 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 0.15 | 1984.81 | 1843.84 | -122.13 | 5.8 |
| Yil/Yil | 171.53 | 839.31 | 759.02 | -14.24 | 7.8 |
| 3 yil o‘rtacha | 193.06 | 24.53 | 26.09 | 51.72 | 10 |
| 5 yil o‘rtacha | 216.04 | 8.69 | 11.97 | 19.07 | 8.0 |
| O‘rtacha ball | 7.9 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Zaif | 3.0 |
| Nomoddiy aktivlar | Kuchli | 8.0 |
| O'zgartirish xarajatlari | O'rtacha | 6.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Zaif | 4.0 |
| O‘rtacha ball | 4.4 | |